Literature DB >> 33426933

Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice.

Toby Richards1, Christian Breymann2, Matthew J Brookes3,4, Stefan Lindgren5, Iain C Macdougall6, Lawrence P McMahon7, Malcolm G Munro8,9, Elizabeta Nemeth10, Giuseppe M C Rosano11, Ingolf Schiefke12, Günter Weiss13,14.   

Abstract

Iron deficiency is a common cause of morbidity and can arise as a consequence or complication from many diseases. The use of intravenous iron has increased significantly in the last decade, but concerns remain about indications and administration. Modern intravenous iron preparations can facilitate rapid iron repletion in one or two doses, both for absolute iron deficiency and, in the presence of inflammation, functional iron deficiency, where oral iron therapy is ineffective or has not worked. A multidisciplinary team of experts experienced in iron deficiency undertook a consensus review to support healthcare professionals with practical advice on managing iron deficiency in gastrointestinal, renal and cardiac disease, as well as; pregnancy, heavy menstrual bleeding, and surgery. We explain how intravenous iron may work where oral iron has not. We provide context on how and when intravenous iron should be administered, and informed opinion on potential benefits balanced with potential side-effects. We propose how intravenous iron side-effects can be anticipated in terms of what they may be and when they may occur. The aim of this consensus is to provide a practical basis for educating and preparing staff and patients on when and how iron infusions can be administered safely and efficiently. Key messages Iron deficiency treatment selection is driven by several factors, including the presence of inflammation, the time available for iron replenishment, and the anticipated risk of side-effects or intolerance. Intravenous iron preparations are indicated for the treatment of iron deficiency when oral preparations are ineffective or cannot be used, and therefore have applicability in a wide range of clinical contexts, including chronic inflammatory conditions, perioperative settings, and disorders associated with chronic blood loss. Adverse events occurring with intravenous iron can be anticipated according to when they typically occur, which provides a basis for educating and preparing staff and patients on how iron infusions can be administered safely and efficiently.

Entities:  

Keywords:  Anaemia; cardiovascular diseases; chronic; erythrocyte transfusion; inflammatory bowel diseases; infusions; intravenous; iron; iron-deficiency; menorrhagia; pregnancy complications; renal insufficiency

Year:  2021        PMID: 33426933      PMCID: PMC7877947          DOI: 10.1080/07853890.2020.1867323

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  82 in total

1.  Oral vs intravenous iron therapy for postpartum anemia: a systematic review and meta-analysis.

Authors:  Pervez Sultan; Sohail Bampoe; Raj Shah; Nan Guo; Jaclyn Estes; Christopher Stave; Lawrence Tim Goodnough; Stephen Halpern; Alex James Butwick
Journal:  Am J Obstet Gynecol       Date:  2018-12-19       Impact factor: 8.661

2.  Guidelines for the management of iron deficiency anaemia.

Authors:  Andrew F Goddard; Martin W James; Alistair S McIntyre; Brian B Scott
Journal:  Gut       Date:  2011-05-11       Impact factor: 23.059

3.  FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age.

Authors:  Malcolm G Munro; Hilary O D Critchley; Michael S Broder; Ian S Fraser
Journal:  Int J Gynaecol Obstet       Date:  2011-02-22       Impact factor: 3.561

4.  High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia.

Authors:  Robert Stöhr; Lukas Sandstede; Gunnar H Heine; Nikolaus Marx; Vincent Brandenburg
Journal:  J Am Coll Cardiol       Date:  2018-05-15       Impact factor: 24.094

Review 5.  Prevention and management of acute reactions to intravenous iron in surgical patients.

Authors:  Susana Gómez-Ramírez; Aryeh Shander; Donat R Spahn; Michael Auerbach; Giancarlo M Liumbruno; Stefania Vaglio; Manuel Muñoz
Journal:  Blood Transfus       Date:  2018-10-16       Impact factor: 3.443

6.  Rapid increase in intravenous iron therapy for women of reproductive age in Australia.

Authors:  Sallie Pearson; Natasha Nassar; Antonia W Shand; Jane Bell; Amanda Henry; Luke E Grzeskowiak; Giselle Kidson-Gerber
Journal:  Med J Aust       Date:  2020-05-26       Impact factor: 7.738

Review 7.  Anaemia in inflammatory bowel disease.

Authors:  Martyn Dibb; Sreedhar Subramanian
Journal:  Frontline Gastroenterol       Date:  2014-01-03

8.  First trimester ferritin screening for pre-delivery anaemia as a patient blood management strategy.

Authors:  Philip Crispin; Benjamin Stephens; Evelyn McArthur; Farah Sethna
Journal:  Transfus Apher Sci       Date:  2018-12-05       Impact factor: 1.764

9.  Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.

Authors:  Piotr Ponikowski; Bridget-Anne Kirwan; Stefan D Anker; Theresa McDonagh; Maria Dorobantu; Jarosław Drozdz; Vincent Fabien; Gerasimos Filippatos; Udo Michael Göhring; Andre Keren; Irakli Khintibidze; Hans Kragten; Felipe A Martinez; Marco Metra; Davor Milicic; José C Nicolau; Marcus Ohlsson; Alexander Parkhomenko; Domingo A Pascual-Figal; Frank Ruschitzka; David Sim; Hadi Skouri; Peter van der Meer; Basil S Lewis; Josep Comin-Colet; Stephan von Haehling; Alain Cohen-Solal; Nicolas Danchin; Wolfram Doehner; Henry J Dargie; Michael Motro; Javed Butler; Tim Friede; Klaus H Jensen; Stuart Pocock; Ewa A Jankowska
Journal:  Lancet       Date:  2020-11-13       Impact factor: 79.321

10.  Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.

Authors:  Piotr Ponikowski; Dirk J van Veldhuisen; Josep Comin-Colet; Georg Ertl; Michel Komajda; Viacheslav Mareev; Theresa McDonagh; Alexander Parkhomenko; Luigi Tavazzi; Victoria Levesque; Claudio Mori; Bernard Roubert; Gerasimos Filippatos; Frank Ruschitzka; Stefan D Anker
Journal:  Eur Heart J       Date:  2014-08-31       Impact factor: 29.983

View more
  5 in total

Review 1.  [Patient blood management in the preparation for birth, obstetrics and postpartum period].

Authors:  Philipp Helmer; Tobias Schlesinger; Sebastian Hottenrott; Michael Papsdorf; Achim Wöckel; Joachim Diessner; Jan Stumpner; Magdalena Sitter; Tobias Skazel; Thomas Wurmb; Christoph Härtel; Stefan Hofer; Ibrahim Alkatout; Thierry Girard; Patrick Meybohm; Peter Kranke
Journal:  Anaesthesist       Date:  2022-03-02       Impact factor: 1.041

Review 2.  Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology.

Authors:  Ridha I S Alnuwaysir; Martijn F Hoes; Dirk J van Veldhuisen; Peter van der Meer; Niels Grote Beverborg
Journal:  J Clin Med       Date:  2021-12-27       Impact factor: 4.964

3.  The Importance of Iron Administration in Correcting Anaemia After Major Surgery.

Authors:  Mirela Tiglis; Cristian Cobilinschi; Liliana Elena Mirea; Alexandru Emil Băetu; Ileana Peride; Tiberiu Paul Neagu; Andrei Niculae; Ionel Alexandru Checherită; Ioana Marina Grintescu
Journal:  J Crit Care Med (Targu Mures)       Date:  2021-08-05

Review 4.  Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics.

Authors:  Felix Funk; Beat Flühmann; Amy E Barton
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 6.208

Review 5.  Hematinic and Iron Optimization in Peri-operative Anemia and Iron Deficiency.

Authors:  Lachlan F Miles; Toby Richards
Journal:  Curr Anesthesiol Rep       Date:  2022-01-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.